Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shuntaro Ikegawa, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kondo T, Fujii N, Fujii K, Sumii Y, Urata T, Kimura M, Matsuda M, Ikegawa S, Washio K, Fujiwara H, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Otsuka F, Maeda Y. Low hematocrit reduces the efficiency of CD34+ cell collection when using the Spectra Optia continuous mononuclear cell collection procedure. Transfusion. 2022 Mar 24. PMID: 35322885.
    Citations:    Fields:    
  2. Yamada Y, Ikegawa S, Najima Y, Atsuta Y, Konuma R, Adachi H, Wada A, Kishida Y, Konishi T, Nagata A, Kaito S, Nagata R, Noguchi Y, Marumo A, Mukae J, Inamoto K, Toya T, Igarashi A, Kobayashi T, Sakamaki H, Ohashi K, Doki N. Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI. Int J Hematol. 2022 Feb; 115(2):244-254. PMID: 34652634.
    Citations:    Fields:    Translation:Humans
  3. Ikegawa S, Matsuoka KI. Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives. Front Immunol. 2021; 12:713358. PMID: 34526990.
    Citations:    Fields:    Translation:HumansAnimalsCells
  4. Nakamura M, Meguri Y, Ikegawa S, Kondo T, Sumii Y, Fukumi T, Iwamoto M, Sando Y, Sugiura H, Asada N, Ennishi D, Tomida S, Fukuda-Kawaguchi E, Ishii Y, Maeda Y, Matsuoka KI. Reduced dose of PTCy followed by adjuvant a-galactosylceramide enhances GVL effect without sacrificing GVHD suppression. Sci Rep. 2021 06 23; 11(1):13125. PMID: 34162921.
    Citations: 1     Fields:    Translation:AnimalsCells
  5. Kondo T, Ikegawa S, Fukumi T, Sumii Y, Sugiura H, Sando Y, Nakamura M, Meguri Y, Iwamoto M, Maeda Y, Matsuoka KI. Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T Cells. Immunohorizons. 2021 06 10; 5(6):424-437. PMID: 34112701.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  6. Sugiura H, Matsuoka KI, Fukumi T, Sumii Y, Kondo T, Ikegawa S, Meguri Y, Iwamoto M, Sando Y, Nakamura M, Toji T, Ishii Y, Maeda Y. Donor Treg expansion by liposomal a-galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft-versus-host disease. Immun Inflamm Dis. 2021 09; 9(3):721-733. PMID: 33942544.
    Citations: 2     Fields:    Translation:HumansCells
  7. Fujii K, Fujii N, Kondo T, Mitsuhashi T, Nakamura M, Seike K, Sando Y, Kimura M, Matsuda M, Ikegawa S, Sugiura H, Otsuka F, Maeda Y. Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection. Transfus Apher Sci. 2021 Aug; 60(4):103147. PMID: 33931360.
    Citations:    Fields:    Translation:HumansCellsCTClinical Trials
  8. Sando Y, Matsuoka KI, Sumii Y, Kondo T, Ikegawa S, Sugiura H, Nakamura M, Iwamoto M, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Utsunomiya A, Oka T, Maeda Y. Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Sci Rep. 2021 Mar 15; 11(1):6420. PMID: 33723351.
    Citations:    Fields:    
  9. Ikegawa S, Meguri Y, Mizuhara K, Fukumi T, Kobayashi H, Sumii Y, Kondo T, Sando Y, Iwamoto M, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Fujisawa Y, Imai T, Maeda Y, Matsuoka KI. Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab. Leukemia. 2021 03; 35(3):929-931. PMID: 33597730.
    Citations: 2     Fields:    Translation:Cells
  10. Iwamoto M, Ikegawa S, Kondo T, Meguri Y, Nakamura M, Sando Y, Sugiura H, Sumii Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Shibakura M, Maeda Y, Matsuoka KI. Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease. Bone Marrow Transplant. 2021 04; 56(4):956-959. PMID: 33128029.
    Citations: 2     Fields:    Translation:HumansCells
  11. Sando Y, Matsuoka KI, Sumii Y, Kondo T, Ikegawa S, Sugiura H, Nakamura M, Iwamoto M, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Utsunomiya A, Oka T, Maeda Y. 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Sci Rep. 2020 10 14; 10(1):17237. PMID: 33057055.
    Citations: 2     Fields:    Translation:HumansCells
  12. Ikegawa S, Meguri Y, Kondo T, Sugiura H, Sando Y, Nakamura M, Iwamoto M, Maeda Y, Matsuoka KI. PTCy ameliorates GVHD by restoring regulatory and effector T-cell homeostasis in recipients with PD-1 blockade. Blood Adv. 2019 12 10; 3(23):4081-4094. PMID: 31821459.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  13. Sugiura H, Matsuoka KI, Sando Y, Meguri Y, Ikegawa S, Nakamura M, Iwamoto M, Yoshioka T, Asano T, Kondo E, Fujii K, Fujii N, Maeda Y. Plasma exchange eliminates residual mogamulizumab but does not warrant prompt recovery of peripheral Treg levels. Transfus Apher Sci. 2019 Aug; 58(4):472-474. PMID: 31303512.
    Citations: 2     Fields:    Translation:HumansCells
  14. Sugiura H, Matsuoka KI, Matsuda M, Ikegawa S, Inomata T, Kuroi T, Asano T, Yoshida S, Nishimori H, Fujii K, Fujii N, Maeda Y. Macrophage elimination in bone marrow by dexamethasone palmitate is associated with successful engraftment in patients with hemophagocytic syndrome. Int J Hematol. 2019 08; 110(2):260-262. PMID: 31098853.
    Citations:    Fields:    Translation:HumansCells
  15. Adachi H, Doki N, Hino Y, Senoo Y, Ikegawa S, Watanabe D, Inamoto K, Yoshioka K, Najima Y, Kobayashi T, Kakihana K, Haraguchi K, Kitahara Y, Okuyama Y, Sakamaki H, Ohashi K. [Transfusion-associated circulatory overload with pulmonary alveolar hemorrhage following allogeneic bone marrow transplantation]. Rinsho Ketsueki. 2019; 60(4):296-301. PMID: 31068559.
    Citations:    Fields:    Translation:Humans
  16. Harada K, Sekiya N, Ikegawa S, Sasaki S, Kobayashi T, Ohashi K. Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemia. Int J Hematol. 2019 Feb; 109(2):233-238. PMID: 30291557.
    Citations: 1     Fields:    Translation:Humans
  17. Nakamura M, Fujii N, Shimizu K, Ikegawa S, Seike K, Inomata T, Sando Y, Fujii K, Nishimori H, Matsuoka KI, Morimatsu H, Maeda Y. Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation. Int J Hematol. 2018 Dec; 108(6):622-629. PMID: 30238198.
    Citations: 2     Fields:    Translation:Humans
  18. Sasaki R, Ohta Y, Yamada Y, Tadokoro K, Takahashi Y, Sato K, Shang J, Takemoto M, Hishikawa N, Yamashita T, Yasuhara T, Date I, Ikegawa S, Fujii N, Abe K. Neurolymphomatosis in the Cauda Equina Diagnosed by an Open Biopsy. Intern Med. 2018 Dec 01; 57(23):3463-3465. PMID: 30101916.
    Citations: 2     Fields:    Translation:Humans
  19. Ikegawa S, Fujii N, Tadokoro K, Sato K, Iwamoto M, Matsuda M, Inomata T, Sugiura H, Asano T, Yoshida S, Nishimori H, Matsuoka KI, Maeda Y. Progressive multifocal leukoencephalopathy after T-cell replete HLA-haploidentical transplantation with post-transplantation cyclophosphamide graft-versus-host disease prophylaxis. Transpl Infect Dis. 2018 Apr; 20(2):e12850. PMID: 29359846.
    Citations: 1     Fields:    Translation:Humans
  20. Ikegawa S, Matsuoka KI, Inomata T, Ikeda N, Sugiura H, Kuroi T, Asano T, Yoshida S, Nishimori H, Fujii N, Kondo E, Maeda Y, Tanimoto M. Mild renal dysfunction defined by creatinine clearance rate has limited impact on clinical outcomes after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2018 May; 107(5):568-577. PMID: 29299798.
    Citations: 2     Fields:    Translation:Humans
  21. Hino Y, Doki N, Kurosawa S, Yamamoto K, Sakaguchi M, Harada K, Ikegawa S, Shingai N, Hattori K, Senoo Y, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Erythrocytosis after allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2017 04; 31(4). PMID: 28247439.
    Citations:    Fields:    Translation:Humans
  22. Ikegawa S, Doki N, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia. Pathol Oncol Res. 2017 Apr; 23(2):433-437. PMID: 28004352.
    Citations: 3     Fields:    Translation:Humans
  23. Hattori K, Doki N, Kurosawa S, Hino Y, Yamamoto K, Sakaguchi M, Harada K, Ikegawa S, Shingai N, Senoo Y, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2017 Feb; 96(2):319-321. PMID: 27766393.
    Citations: 2     Fields:    Translation:Humans
  24. Kakihana K, Fujioka Y, Suda W, Najima Y, Kuwata G, Sasajima S, Mimura I, Morita H, Sugiyama D, Nishikawa H, Hattori M, Hino Y, Ikegawa S, Yamamoto K, Toya T, Doki N, Koizumi K, Honda K, Ohashi K. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood. 2016 10 20; 128(16):2083-2088. PMID: 27461930.
    Citations: 128     Fields:    Translation:HumansCellsCTClinical Trials
  25. Hino Y, Doki N, Yamamoto K, Senoo Y, Sasajima S, Sakaguchi M, Hattori K, Kaito S, Kurosawa S, Harada K, Ikegawa S, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation. Rinsho Ketsueki. 2016 05; 57(5):608-12. PMID: 27263786.
    Citations: 1     Fields:    Translation:Humans
  26. Harada K, Kurosawa S, Hino Y, Yamamoto K, Sakaguchi M, Ikegawa S, Hattori K, Igarashi A, Watakabe K, Senoo Y, Najima Y, Hagino T, Doki N, Kobayashi T, Kakihana K, Iino T, Sakamaki H, Ohashi K. Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease. Springerplus. 2016; 5:512. PMID: 27186476.
    Citations: 6     
  27. Kurosawa S, Doki N, Kaito S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, Ikegawa S, Yosioka K, Watanabe D, Senoo Y, Watakabe K, Hagino T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Miyawaki S, Sakamaki H, Ohashi K. [Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis]. Rinsho Ketsueki. 2016 Apr; 57(4):461-6. PMID: 27169451.
    Citations:    Fields:    Translation:Humans
  28. Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Watanabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes. Leuk Lymphoma. 2016; 57(1):76-80. PMID: 26084204.
    Citations: 7     Fields:    Translation:Humans
  29. Senoo Y, Yoshioka K, Kaito S, Kurosawa S, Harada K, Yamamoto K, Hino Y, Sakaguchi M, Ikegawa S, Watanabe D, Watakabe K, Hagino T, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experience. Rinsho Ketsueki. 2016; 57(12):2481-2489. PMID: 28090014.
    Citations:    Fields:    Translation:Humans
  30. Ikegawa S, Najima Y, Sano N, Horiguchi SI, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, Senoo Y, Watanabe D, Yoshioka K, Watakabe K, Igarashi A, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Hishima T, Ohashi K. Donor cell leukemia with bone marrow necrosis. Rinsho Ketsueki. 2016; 57(11):2334-2338. PMID: 27941282.
    Citations: 1     Fields:    Translation:Humans
  31. Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Hattori K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K. CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission. Leuk Lymphoma. 2016; 57(6):1375-81. PMID: 26422713.
    Citations: 5     Fields:    Translation:Humans
  32. Oshikawa G, Yoshioka K, Takahashi Y, Shingai N, Ikegawa S, Kobayashil T, Doki N, Kakihana K, Ohashi K, Sakamaki H. Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndrome. Pathol Oncol Res. 2015 Sep; 21(4):1037-43. PMID: 25837848.
    Citations: 4     Fields:    Translation:Humans
  33. Ikegawa S, Doki N, Yamamoto K, Shingai N, Takahashi Y, Aoki J, Yoshioka K, Narukawa K, Ishida S, Igarashi A, Oshikawa G, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K. Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia. Leuk Lymphoma. 2015 Jun; 56(6):1874-7. PMID: 25311493.
    Citations: 1     Fields:    Translation:Humans
  34. Kizaki M, Nomura T, Ikegawa S, Takahashi N, Uchida N. [Discussion meeting on the daily practice of leukemia]. Nihon Naika Gakkai Zasshi. 2013 Jul 10; 102(7):1767-82 ; quiz 1783-9. PMID: 23947240.
    Citations:    Fields:    Translation:Humans
  35. Ikegawa S, Hiraoka A, Shimizu Y, Hidaka S, Tazuya N, Ichiryu M, Nakahara H, Tanabe A, Tanihira T, Hasebe A, Miyamoto Y, Ninomiya T, Hirooka M, Kumagi T, Abe M, Hiasa Y, Onji M, Michitaka K. Hepatocellular carcinoma in a case of Wilson's disease treated with radiofrequency ablation therapy. Intern Med. 2011; 50(13):1433-7. PMID: 21720066.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Ikegawa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (157)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.